Study-level AUC
0.98 proportion
- EndpointROC discrimination for three or more acute rib fractures
- PopulationChest CT cases from five U.S. clinical sites
- Tested versionBriefCase rib-fracture triage release reviewed in FDA submission K230020
FDA-cleared profile
Aidoc Medical, Ltd. · CT/CTA · FDA-cleared (510(k))
Authorized purpose: Chest CT (with or without contrast) triage and notification for suspected three or more acute rib fractures in adults or transitional adolescents age 18 or older; notifications are non-diagnostic and clinicians review the original study.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Chest CT (with or without contrast) triage and notification for suspected three or more acute rib fractures in adults or transitional adolescents age 18 or older; notifications are non-diagnostic and clinicians review the original study.
Evidence takeaway. Evidence from the reviewed source record: K230020's exact FDA pivotal study evaluated 308 chest CT cases at five U.S. sites against majority-vote ground truth from three senior board-certified radiologists. The study reported observed AUC, sensitivity, specificity and notification-time results; its performance goals were thresholds and are kept separate from the observed values.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
0.98 proportion
98.08 percent
93.14 percent
70.1 seconds
K230020
The FDA summary reports the study and vendor submission; independent-investigator status was not established.
Aidoc official clinical study page
The page reports 75 fractures not mentioned in written reports and potential reading assistance. This family/prototype evidence must not be used as K230020 release performance.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Filtered DICOM chest CT images, with or without contrast, processed chronologically by series.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-07 · FDA 510(k) decision summary K230020: BriefCase RibFx triage
Source context, not route validation: Uses DICOM CT input, an image communication or routing platform for acquisition, an algorithm module for processing, and a desktop application/feed with a non-diagnostic viewer for workflow integration; clinicians return to the local PACS for full-image review.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-07 · FDA 510(k) decision summary K230020: BriefCase RibFx triage
Source context, not route validation: The exact FDA description places the algorithm on a Linux-based server in a cloud environment and describes processing through a compatible image communication platform before notification reaches the desktop application.
Scope: Exact FDA submission. This is the submission-era architecture; current tenant, hosting, security and contract terms require vendor confirmation.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-07 · FDA 510(k) decision summary K230020: BriefCase RibFx triage
Source context, not route validation: A desktop notification for a suspected RibFx case and a compressed, low-quality, grayscale, unannotated preview captioned for prioritization only; the original medical image is not altered.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-07 · FDA 510(k) decision summary K230020: BriefCase RibFx triage
Unresolved route: A desktop notification for a suspected RibFx case and a compressed, low-quality, grayscale, unannotated preview captioned for prioritization only; the original medical image is not altered.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-07 · FDA 510(k) decision summary K230020: BriefCase RibFx triage
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
This is the submission-era architecture; current tenant, hosting, security and contract terms require vendor confirmation.
Vendor-wide marketing statement, not an independent attestation. It does not establish certificate scope or expiry, the controls of this exact release, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.
Vendor statement, not an attestation. The page names Aidoc's platform generally and does not scope these capabilities to any specific product release; exact-release scope is not established. The page lists technology categories in use; it states no uptime, alerting or response-time SLAs.
The exact FDA record describes filtered DICOM CT acquisition, algorithm processing, and a desktop feed/preview that prompts review of the original study in local PACS without changing or deprioritizing the standard worklist.
exact submission · checked 2026-09-07Aidoc's current radiology page describes deep integrations with EHR, PACS, scheduling and reporting; its Widget runs on the workstation and places AI triage results directly in the worklist with key images and a summary of AI results.
product family · checked 2026-09-07Current family platform context is buyer-relevant but does not establish the exact K230020 tenant, release or contractual interfaces.
Aidoc's official Atlantic Health announcement describes deployment across several hospitals, where physicians use Aidoc AI to triage CT scans and receive alerts for potential rib fractures and other findings.
product family · checked 2026-09-07This is a vendor-reported family deployment example, not evidence that the exact K230020 configuration was installed there.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The stored PubMed and ClinicalTrials candidate metadata were screened in the exact stored order; this was metadata triage, not full-text paper or registry-record review, and no candidate was promoted. The stored recall query returned no records, so no event was promoted and no absence claim is made. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor clinical study, vendor press release, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public exact-submission price or procurement terms were reviewed.
Bounded web search on 2026-10-26 (query: "Aidoc BriefCase reimbursement NTAP CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. Aidoc's 2026-08-13 release announces a Medicare NTAP for CARE Body CT Multi-Triage; it does not name this product or clearance. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
11 sources - 3 history items
Scope: regulatoryIdentity, purpose, modality, anatomy
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: identity, clinicalUse, purpose, modality, anatomy, input, output, limitations, deployment, integration, evidenceSummary, evidenceMetrics, evidenceStudies
Scope: product_family, workflow, PACS_integration, EHR_integration, worklist, implementationCapabilities
Scope: product_family, clinical_evidence, rib_fracture_workflow
Scope: product_family, hospital_deployment, CT_triage, implementationCapabilities
Scope: security
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Aidoc Medical, Ltd.
Authorized purpose: Chest and abdominal CT triage and notification for suspected vertebral compression fractures in the standard-of-care bone-health workflow; notifications are non-diagnostic and clinicians review the original study.
Shanghai United Imaging Intelligence Co., Ltd.
Authorized purpose: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
V5med Inc.
Authorized purpose: V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.
Aidoc Medical, Ltd.
Authorized purpose: BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of CTPA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspected positive findings of Pulmonary Embolism (PE) pathologies. Briefcase uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a Stand-Alone Performance desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device. The results of BriefCase are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history